Cases 1 - 5 of 5
Janssen Pharmaceuticals, Inc. et al v. Mylan Laboratories Limited et al
as 1:2019cv00153
Plaintiff:
Janssen Pharmaceutica N.V. and Janssen Pharmaceuticals, Inc.
Defendant:
Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. and Mylan Institutional LLC
Cause Of Action: 35 U.S.C. § 271
Javelin Pharmaceuticals, Inc. et al v. Mylan Laboratories Limited et al
as 1:2016cv00059
Plaintiff:
Javelin Pharmaceuticals, Inc. , Hospira, Inc. and Janssen Pharmaceutica N.V.
Defendant:
Mylan Laboratories Limited, Mylan Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Janssen Pharmaceutica, N.V. et al v. Mylan Pharmaceuticals, Inc. et al
as 1:2015cv00152
Plaintiff:
Janssen Pharmaceutica, N.V. , Janssen Sciences Ireland UC , Gilead Sciences, Inc. and others
Defendant:
Mylan Pharmaceuticals, Inc. and Mylan, Inc.
Counter_claimant:
Mylan Pharmaceuticals, Inc. and Mylan, Inc.
Counter_defendant:
Gilead Sciences Ireland UC , Gilead Sciences, Inc. , Janssen Pharmaceutica, N.V. and others
Cause Of Action: 35 U.S.C. § 271
Janssen Pharmaceutica, N.V. v. Kappos et al
as 1:2011cv01091
Plaintiff:
Janssen Pharmaceutica, N.V.
Defendant:
David J. Kappos and United States Patent and Trademark Office
Cause Of Action: 05 U.S.C. § 0706
Janssen Pharmaceutica, N.V. v. Kappos et al
as 1:2011cv00969
Plaintiff:
Janssen Pharmaceutica, N.V.
Defendant:
David J. Kappos and United States Patent and Trademark Office
Cause Of Action: 15 U.S.C. § 1692
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
